Ajinomoto BioPharma Europe

Ajinomoto BioPharma Europe is owned by Ajinomoto BioPharma.

Ajinomoto is one of the...

• Forbes Global 2000 (#1365);
• Nikkei 225;
• Topix.

Ajinomoto is a company listed under the stock ticker 2802 (JP).

Ajinomoto has a direct presence in 3 countries.

Ajinomoto has 4 subsidiaries including Ajinomoto BioPharma, Ajinomoto BioPharma Europe and Ajinomoto Cambrooke.

They are in:

• Pharmaceuticals60%
• Food40%

View the org chart displaying its 6 main executives

Most searched biographies at Ajinomoto BioPharma Europe

• Mark Cassidy, President and Chief Executive Officer
• Raymond Bruynseraede, Head of Human Resources
• Eric De Vos, Vice President of Global Innovation and Director of R...

Create an alert
to follow the executive moves at Ajinomoto BioPharma Europe.

Ajinomoto has 1,993 competitors including Johnson & Johnson (United States (USA)), Pfizer (United States (USA)) and Roche (Switzerland).

Popular M&A news in Pharmaceuticals

• Regeneron Pharmaceuticals has announced the acquisition of Checkmate Pharmaceuticals  (posted on May 31 2022).
• Zentalis Pharmaceuticals has just announced a $200 Million fundraising. (posted on May 19 2022).
• Pfizer has announced the acquisition of Biohaven Pharmaceutical  (posted on May 12 2022).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Director at Johnson & Johnson
• Richard Gonzalez - Chairman and Chief Executive Officer at AbbVie
• Keith Goldan - Chief Financial Officer at Syndax Pharmaceuticals

Learn more about the Pharmaceuticals industry >

Press releases by Ajinomoto BioPharma Europe

Social media about Ajinomoto BioPharma Europe

• Ajinomoto BioPharma Europe on Wikipedia, Google News & Yahoo Finance
• Ajinomoto BioPharma Europe on LinkedIn, Twitter & YouTube

Call Ajinomoto BioPharma Europe at +32 ...

View the org chart

Register to receive your alert

Report an error